The mitogenic effectors of isoproterenol in human hepatocellular carcinoma cells

Oncology Reports

Volumn 23, Issue 1, 2010, Pages 151-157

  Yuan, Aihua ^a,b   Li, Zongfang ^b   Li, Xinqiu ^c   Yi, Shanyong ^c   Wang, Shukui ^a   Cai, Yongdong ^a   Cao, Hongyong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Adrenergic receptor; Extracellular signal regulated kinase 1 2; Hepatocellular carcinoma; Isoproterenol; Stress hormone

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; ALPHA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; COMPLEMENTARY DNA; ISOPRENALINE; MITOGENIC AGENT; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; RNA; UO 126;

APOPTOSIS; ARTICLE; CANCER CELL; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MITOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADRENERGIC BETA-AGONISTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOPROTERENOL; LIVER NEOPLASMS; MITOGENS;

EID: 76049108120     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000616     Document Type: Article

References (22)

1. Antoni MH, Lutgendorf SK, Cole SW, Dhabhar FS, Sephton SE, McDonald PG, Stefanek M and Sood AK: The influence of biobehavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 6: 240-248, 2006.
2. Dorsam RT and Gutkind JS: G-protein-coupled receptors and cancer. Nat Rev Cancer 7: 79-94, 2007.
3. Cip1/WAF1-dependent pathway. FEBS Lett 436: 131-138, 1998.
4. Scaparo AC, Sumida DH, Patrao MT, Avellar MC, Visconti MA, De Lauro M and Castrucci A: Catecholamine effects on human melanoma cells evoked by alpha1-adrenoceptors. Arch Dermatol Res 296: 112-119, 2004.
5. Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, Sanguino AM, Newman RA, Lloyd M, Gershenson DM, Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW and Sood AK: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12: 939-944, 2006.
6. Palm D, Lang K, Niggemann B, Drell TL, Masur K, Zaenker KS and Entschladen F: The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/C nude mice is inhibited by beta-blockers. Int J Cancer 118: 2744-2749, 2006.
7. Masur K, Niggemann B, Zanker KS and Entschladen F: Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by βblockers. Cancer Res 61: 2866-2869, 2001.
8. Thomas MB and Zhu AX: Hepatocellular carcinoma: The need for progress. J Clin Oncol 23: 2892-2899, 2005.
9. Atesci FC, Cetin BC, Oguzhanoglu NK, Karadag F and Turgut H: Psychiatric disorders and functioning in hepatitis B virus carriers. Psychosomatics 46: 142-147, 2005.
10. Nagano J, Nagase S, Sudo N and Kubo C: Psychosocial stress, personality, and the severity of chronic hepatitis C. Psychosomatics 45: 100-106, 2004.
11. Bianchi G, Marchesini G, Nicolino F, Graziani R, Sgarbi D, Loguercio C, Abbiati R and Zoli M: Psychological status and depression in patients with liver cirrhosis. Dig Liver Dis 37: 593-600, 2005.
12. Bevilacqua M, Norbiato G, Chebat E, Baldi G, Bertora P, Regalia E, Colella G, Gennari L and Vago T: Changes in alpha-1 and beta-2 adrenoceptor density in human hepatocellular carcinoma. Cancer 67: 2543-2551, 1991.
13. Refsnes M, Thoresen GH, Sandnes D, Dajani OF, Dajani L and Christoffersen T: Stimulatory and inhibitory effects of catecholamines on DNA synthesis in primary rat hepatocyte cultures: role of alpha 1- and beta-adrenergic mechanisms. J Cell Physiol 151: 164-171, 1992.
14. Hamasaki K, Nakashima M, Naito S, Akiyama Y, Ohtsuru A, Hamanaka Y, Hsu CT, Ito M and Sekine I: The sympathetic nervous system promotes carbon tetrachloride-induced liver cirrhosis in rats by suppressing apoptosis and enhancing the growth kinetics of regenerating hepatocytes. J Gastroenterol 36: 111-120, 2001.
15. Refsnes M, Sager G, Andnes SD, Sand TE, Jacobsen S and Christoffersen T: Increased number of βadrenoceptors in hepatocytes from rats treated with 2-acetylamino-fluorene. Cancer Res 46: 2285-2288, 1986.
16. Boyd H, Louis C and Martin TJ: Activity and hormone responsiveness of Adenyl cyclase during induction of tumors in rat liver with 3′-methyl-4- dimethylaminoazobenzene. Cancer Res 34: 1720-1725, 1974.
17. Weddle DL, Tithoff P, Williams M and Schuller HM: β-drenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas. Carcinogenesis 22: 473-479, 2001.
18. Liu X, Wu WK, Yu L, Li ZJ, Sung JY, Zhang ST and Cho CH: Epidermal growth factor-induced esophageal cancer cell proliferation requires transactivation of βadrenoceptors. J Pharmacol Exp Ther 326: 69-75, 2008.
19. Pullar CE and Isseroff RR: The β2-adrenergic receptor activates pro-migratory and pro-proliferative pathways in dermal fibroblasts via divergent mechanisms. J Cell Sci 119: 592-602, 2006.
20. Tsuboi Y, Ichida T, Sugitani S, Genda T, Inayoshi J, Takamura M, Matsuda Y, Nomoto M and Aoyagi Y: Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma. Liver Int 24: 432-436, 2004.
21. Schmitz KJ, Wohlschlaeger J, Lang H, Sotiropoulos GC, Malago M, Steveling K, Reis H, Cicinnati VR, Schmid KW and Baba HA: Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J Hepatol 48: 83-90, 2008.
22. Kovach SJ, Price JA, Shaw CM, Theodorakis NJ and Mckkillop IH: Role of cyclic-AMP responsive element binding (CREB) proteins in cell proliferation in a rat model of hepatocellular carcinoma. J Cellular Physiol 206: 411-419, 2006.